MedPath

Jenapharm GmbH & Co. KG

Jenapharm GmbH & Co. KG logo
🇩🇪Germany
Ownership
Subsidiary
Established
1942-01-01
Employees
11
Market Cap
-
Website
http://www.jenapharm.de

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Estradiol Valerate Tablets

Product Name
补佳乐
Approval Number
国药准字HJ20160678
Approval Date
Jan 22, 2025
NMPA

Estradiol Valerate Tablets

Product Name
补佳乐
Approval Number
国药准字HJ20160679
Approval Date
Jan 22, 2025
NMPA

Dienogest Tablets

Product Name
唯散宁
Approval Number
国药准字HJ20180090
Approval Date
Nov 16, 2022
NMPA

Estradiol and Drospirenone Tablets

Product Name
安今益
Approval Number
国药准字HJ20181191
Approval Date
Aug 31, 2022
NMPA

Estradiol and Drospirenone Tablets

Product Name
安今益
Approval Number
国药准字HJ20181189
Approval Date
Aug 31, 2022
NMPA

Complex Packing Estradiol Valerate Tablets, Estradiol Valerate and Cyproterone Acetate Tablets

Product Name
克龄蒙
Approval Number
国药准字HJ20160683
Approval Date
Sep 4, 2020
NMPA

Complex Packing Estradiol Valerate Tablets, Estradiol Valerate and Cyproterone Acetate Tablets

Product Name
克龄蒙
Approval Number
国药准字HJ20160682
Approval Date
Sep 4, 2020
NMPA

Estradiol Valerate Tablets

Product Name
补佳乐
Approval Number
国药准字J20171038
Approval Date
Jul 9, 2020
NMPA

Estradiol Valerate Tablets

Product Name
补佳乐
Approval Number
H20160678
Approval Date
Feb 25, 2020
NMPA

Estradiol Valerate Tablets

Product Name
补佳乐
Approval Number
H20160679
Approval Date
Feb 25, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.